Article
Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.
Breast cancer research and treatment - 1 Aug 2009
Rao Nan-Yan, Hu Zhen, Yu Jin-Ming, Li Wen-Feng, Zhang Bin, Su Feng-Xi, Wu Jiong, Shen Zhen-Zhou, Huang Wei, Shao Zhi-Ming
Abstract excerpt
PURPOSE: Established models (Penn, Myraid and BRCApro) are useful of estimating the probability that a person has a BRCA mutation. But the value of these models in Chinese population is unclear. The aim of the study is to evaluate the performance of three models on the assisting in pre-test genetic risk counseling. METHODS: Three risk assessment models, Penn II, Myriad and BRCApro, were applied to 212 familial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
